The medicine "Emoksipin", its analogues (medicines "Emoksibel", "Cardioksipin" and others) belong to drugs with retinoprotective properties. Used drugs in ophthalmology.
The medicine "Emoksipin" describes the instructions for use as a corrector of microcirculation, an antioxidant with antiaggregate, angioprotective and antihypoxic properties. The drug is available in the form of eye drops and an injection. The active ingredient is methylethylpyridinol.
Eye drops "Emoksipin" reduce capillary permeability, strengthen vascular walls. The drug has a membrane-stabilizing effect, prevents platelet aggregation (gluing), reduces blood viscosity and coagulation. The medicine helps to increase the resistance of the brain and heart to hypoxia and ischemia.
The retinoprotective properties of the eye drops protect the eye tissue, including the retina, from the damaging effects of high-intensity light. The medicine also contributes to the resorption of hemorrhages inside the eye.
The drug "Emoxipin". Instructions for use. Appointment
The medicine is indicated for the prevention and treatment of pathologies complicated by hypoxia and increased lipid peroxidation.
In ophthalmology, drops are used for hemorrhages in the sclera, the anterior eye chamber, after eye injuries. The use of the drug for cataracts is recommended for its prevention in patients after forty years. The tool "Emoksipin" instructions for use recommends use for retinal dystrophy, burns and inflammation of the cornea. Indications also include diabetic retinopathy, complications of myopia (myopia). The use of drops "Emoksipin" is recommended for thrombosis of the central retinal vein and its branches. A medication is used in the period after surgical interventions in the eyes, including with detachment of the choroid and glaucoma. Drops for eyes are recommended to be used to protect the retina from the negative effects of high-intensity rays and the cornea when using contact lenses.
In neurology, the medicine "Emoxipin" is prescribed for hemorrhagic and ischemic brain circulatory disorders in the chronic and acute phase, with head injury, after interventions for sub- and epidural hematomas.
Dosage regimen
In ophthalmology, the drug is used in the form of drops and injections (parabulbar, subconjunctival, retrobulbar).
In the conjunctival sac instill two to three times a day, one or two drops. Duration of use is from three to thirty days. In case of good tolerance, the duration of the course can be increased to six months, therapy can be repeated.
In neurology, an Emoxipin solution is administered intramuscularly. The dosage is three to five milliliters two or three times a day, ten to thirty days. Drop solution is allowed.
A more accurate dose and method of administration for a given disease is established by a specialist.
Contraindications
The drug "Emoksipin" instruction for use does not recommend for hypersensitivity to the components. No medicine is prescribed during pregnancy. If necessary, use the drug for lactation, you need to consult a doctor.
Side effects
As practice shows, the medicine is well tolerated by patients. The most common negative effect is a feeling of irritation, burning when instilled into the conjunctival region.
special instructions
The use of the drug "Emoksipin" is carried out with the systematic monitoring of blood coagulation and blood pressure.
Before using the drug, you should consult a doctor.